RAPT Therapeutics (RAPT)
NASDAQ:RAPT

RAPT Therapeutics (RAPT) Technical Analysis

270 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
13Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
RAPT Therapeutics’s (RAPT) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting RAPT Therapeutics is a Sell.
RAPT Therapeutics’s (RAPT) 20-Day exponential moving average is 3.39, while RAPT Therapeutics’s (RAPT) share price is $3.29, making it a Sell.
RAPT Therapeutics’s (RAPT) 50-Day exponential moving average is 4.36, while RAPT Therapeutics’s (RAPT) share price is $3.29, making it a Sell.

RAPT Therapeutics (RAPT) Pivot Points

Jul 26, 2024, 06:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.00
3.20
3.31
3.51
3.62
3.82
3.93
Fibonacci
3.20
3.32
3.39
3.51
3.63
3.70
3.82
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RAPT Therapeutics (RAPT) Moving Averages

Jul 26, 2024, 06:39 AM
Period
Simple
Exponential
MA5
3.54Sell
3.44Sell
MA10
3.41Sell
3.39Sell
MA20
3.19Buy
3.39Sell
MA50
3.74Sell
4.36Sell
MA100
6.08Sell
6.95Sell
MA200
12.14Sell
11.31Sell
RAPT Therapeutics’s (RAPT) 10-Day exponential moving average is 3.39, while RAPT Therapeutics’s (RAPT) share price is $3.29, making it a Sell.
RAPT Therapeutics’s (RAPT) 100-Day exponential moving average is 6.95, while RAPT Therapeutics’s (RAPT) share price is $3.29, making it a Sell.
RAPT Therapeutics’s (RAPT) stock price is $3.29 and RAPT Therapeutics’s (RAPT) 50-day simple moving average is 3.74, creating a Sell signal.
RAPT Therapeutics’s (RAPT) stock price is $3.29 and RAPT Therapeutics’s (RAPT) 100-day simple moving average is 6.08, creating a Sell signal.
RAPT Therapeutics’s (RAPT) stock price is $3.29 and RAPT Therapeutics’s (RAPT) 200-day simple moving average is 12.14, creating a Sell signal.

RAPT Therapeutics (RAPT) Technical Indicators

Jul 26, 2024, 06:39 AM
Name
Value
Implied Action
RSI (14)
44.20
Neutral
STOCH (9,6)
62.74
Neutral
STOCHRSI (14)
69.41
Neutral
MACD (12,26)
-0.11
Sell
ADX (14)
25.28
Neutral
Williams %R
-44.03
Buy
CCI (14)
32.26
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
42.23
Neutral
ROC
7.87
Buy
RAPT Therapeutics’s (RAPT) Relative Strength Index (RSI) is 44.20, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Trend Strength Indicator (ADX) is 25.28, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Commodity Channel Index (CCI) is 32.26, creating a Neutral signal.
RAPT Therapeutics’s (RAPT) Price Rate of Change (ROC) is 7.87, creating a Buy signal.

FAQ

Is RAPT a Buy, Hold, or Sell?
Based on RAPT’s technical indicators, RAPT is a Sell.
    What is RAPT’s RSI (14)?
    RAPT’s RSI (14) is 44.20, which suggests RAPT is a Neutral.
      What is RAPT’s MACD?
      RAPT’s MACD is -0.11, which suggests RAPT is a Sell.
        What is RAPT’s 5-day moving average?
        RAPT’s 5-day moving average is 3.54, which suggests RAPT is a Sell.
          What is RAPT’s 20-day moving average?
          RAPT 20-day moving average is 3.19, which suggests RAPT is a Buy.
            What is RAPT’s 50-day moving average?
            RAPT’s 50-day moving average is 3.74, which suggests RAPT is a Sell.
              What is RAPT’s 200-day moving average?
              RAPT’s 200-day moving average is 12.14, which suggests RAPT is a Sell.
                What is RAPT’s Williams % R (14)?
                RAPT’s Williams % R (14) is -44.03, which suggests RAPT is a Buy.
                  What is RAPT’s CCI (14)?
                  RAPT’s CCI (14) is 32.26, which suggests RAPT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis